NMTC
NeuroOne Q4 revenue grows 38% while securing $4.5M order
NeuroOne expects Q4 product revenue of $3.8M, up 38%, and full-year revenue of $10.5M. The company secured a record $4.5M order and enters FY27 with $5.4M in open POs.
NMTC news
Latest 3 stories · newest Oct 5, 2026
NMTC
NeuroOne Robotic Platform Drugs Brain in Experimental Procedures
NeuroOne succeeded in procedures combining robotic drug delivery with electrophysiological monitoring, validating a workflow expected to be recognized as revenue this fiscal quarter.
NMTC
NeuroOne restates Q1 2026 results due to $0.5M revenue overstatement
NeuroOne Medical Technologies will amend its Q1 2026 10-Q filing after identifying a $0.5 million revenue recognition error tied to a customer order modification at quarter-end. The company reaffirms its fiscal 2026 product revenue guidance of at least $10.5 million and says ongoing business operati…
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same NMTC feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/NMTC/newsSTART FREE